openPR Logo
Press release

Global Cancer Biomarkers Market 2023 Insights And Statistics: Industry Size Till 2030

Global Cancer Biomarkers Market 2023 Insights And Statistics:

Market Overview:

The Cancer Biomarkers Market size is anticipated to reach USD 48.52 billion by 2028 from an estimated USD 16.56 billion in 2021, growing at a CAGR of 16.6% globally. Analysis Period 2023 - 2030.

Biomarker testing involves the examination of genes, proteins, and other substances, known as biomarkers or tumor markers, to gather cancer information. Each individual's cancer exhibits a distinct pattern of biomarkers. Biomarkers, which are also referred to as molecular markers or signature molecules, are biological substances found in body tissues, blood, and other bodily fluids. They function as indicators of normal or abnormal processes, as well as various diseases and conditions, as stated by the National Cancer Institute (NCI). These biomarkers can encompass RNA, DNA, proteins, or metabolomics profiles that are specific to tumors.

Key Players For The Global Cancer Biomarkers Market

BioMérieux Inc. (France), INOVIQ (Australia), Bio-Rad Laboratories Inc. (California), Abbott (US), Becton, Dickinson, and Company (US), Merck KgaA (Germany), QIAGEN (Germany), Thermo Fisher Scientific Inc. (US), CENTOGENE N.V. (Germany), PerkinElmer Inc. (US), Siemens Healthcare Private Limited (Germany), and other major players.

Acquire PDF Sample Report + All Related thorough TOC, Graphs and Tables of Global Cancer Biomarkers Market Now:

Market Dynamics:


The growing prevalence of cancer can be attributed to various factors. The aging population plays a significant role. As people live longer, the risk of developing cancer increases, as cancer is primarily a disease of aging. With improved healthcare and life expectancy, more individuals are reaching an age where they are susceptible to cancer. Lifestyle factors contribute to the rise in cancer cases. Unhealthy behaviors such as tobacco and alcohol use, poor diet, sedentary lifestyle, and exposure to environmental pollutants and radiation have been linked to an increased risk of cancer. As these behaviors become more prevalent, so does the incidence of cancer. Environmental factors play a role as well.


Technological advancements have led to the development of more accurate and efficient diagnostic tools for cancer. Advanced imaging techniques, such as positron emission tomography (PET), magnetic resonance imaging (MRI), and high-resolution ultrasound, allow for earlier and more precise detection of tumors. Additionally, molecular diagnostic tests, including genetic profiling and liquid biopsies, enable the identification of specific biomarkers associated with different cancer types, facilitating personalized treatment approaches. Technological developments have paved the way for precision medicine, which involves tailoring treatment strategies

Read More This Research Report: -

The Report Will Include A Major Chapter

•Patent Analysis
•Regulatory Framework
•Technology Roadmap
•BCG Matrix
•Heat Map Analysis
•Price Trend Analysis
•Investment Analysis
•Company Profiling and Competitive Positioning
•Industry Value Chain Analysis
•Market Dynamics and Factors
•Porter's Five Forces Analysis
•Pestle Analysis

Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years.

Market Segmentation

By Biomarker Type, protein biomarker is expected to account for the largest market share in the forecasted period. The protein biomarker is used for the early detection of the breast as well as colonic cancer. Breast cancer and colon cancer are the most common type of cancer and major cause of death around the world. According to WHO, around 2.3 million women were diagnosed with breast cancer and 685,000 death occurred due to breast cancer in 2020 worldwide and 1.9 million people were colonic cancer. The growing cases of breast cancer as well as colon cancer, increase the R&D of the protein biomarkers. For instance, the Food and Drug Administration (FDA) approved the protein biomarkers which contain carcinoembryonic antigen (CEA) in colon cancer, cancer antigen 125 (CA125) in ovarian cancer, and prostate-specific antigen (PSA) in prostate cancer. Thus, the protein biomarkers have maximum growth in the cancer biomarkers market.

By Cancer Type, breast cancer is projected to have the maximum market share in the cancer biomarker market during the analysis period. Breast cancer is one of the most common cancers in women. Breast cancer occurs due to various reasons such as genetic mutation, being overweight, reproductive history, and alcohol drinking. The risk of breast cancer increases the age. In 2020, there were 55% of women aged 65 years old or over. Protein biomarkers are the choice for the treatment of breast cancer. Thus, the growing incidence of breast cancer among women which is the rising demand for biomarkers for treatment propels the growth of the cancer biomarkers market.

By Cancer Biomarkers:

•Genetic Biomarkers
•Protein Biomarkers
•Other Cancer Biomarkers

By Cancer Type:

•Lung Cancer
•Breast Cancer
•Kidney Cancer
•Liver Cancer

By End Users:

•Academic & Cancer Research Institutes
•Cancer Diagnostic Laboratories
•Ambulatory Surgical Centers

Get 50% Discount on This Report:

Introspective Market Research is a globally trusted partner delivering comprehensive market research studies that provide businesses with invaluable insights and strategic guidance, facilitating informed decision-making. Our research approach encompasses an extensive range of primary and secondary sources, ensuring utmost accuracy.
The study offers an in-depth analysis of the Cancer Biomarkers market ecosystem, examining the functions and interdependencies of various market stakeholders. Through our expert utilization of trusted methodologies such as SWOT Analysis, Porter's Five Forces Analysis, and Price Trend Analysis, we provide a comprehensive understanding of the regulatory landscape and prevailing trends.

Regional Analysis Of Cancer Biomarkers Market

North America is the dominant region in the cancer biomarkers market owing to the growing number of cancer patients. The increasing number of tobacco, and alcohol consumption, unhealthy food habits, genetic mutation, hormonal imbalance, growing demand for early diagnosis, and the rising geriatric population in this region. These are the common causes of cancer. For instance, there were 32.51 million Americans smoked cigarettes in the year 2020. Statista stated that in 2020 North America had the highest 12-month rate of the prevalence of cancer. Thus, the incidence of cancer in this region is increased. In the United State, there were236 thousand lung cancer cases diagnosed in 2021. Growing awareness about the treatment of cancer among American people the organizations increasing their investment in research and development of biomarkers for cancer treatment. Growing population with cancer and rising investment in the development of biomarkers people the growth of the cancer biomarkers market in the North American region.

By Region:

•North America (U.S., Canada, Mexico)
•Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
•Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
•Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
•Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
•South America (Brazil, Argentina, Rest of SA)

Inquire Before Purchase: -

Key Industry Development In The Cancer Biomarkers Market

In April 2021, F. Hoffmann-La Roche Ltd. (Switzerland), established Elecsys Anti-p53 immunoassay for the diagnosis of various cancer types.

In December 2020, FDA approves the NGS-based companion diagnostic of Thermo Fisher Scientific (US) for EGFR Exon20 insertion mutant non-small cell lung cancer tumor tissue.

Table of Content:

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Cancer Biomarkers Market by Type

For More Related Reports Click Here:

Buy the Latest Version of this Report @

Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1 773 382 1049

About us:
Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Biomarkers Market 2023 Insights And Statistics: Industry Size Till 2030 here

News-ID: 3146597 • Views: 531

More Releases from Introspective Market Research

Coffee Whitener Market size to increase by USD 27.98 Bn | Driven by growing prominence for online retailing | Introspective Market Research
Coffee Whitener Market size to increase by USD 27.98 Bn | Driven by growing prom …
Market Overview: The global coffee whitener market is estimated to be worth USD 18.1 billion in 2022 and is projected to reach USD 27.98 billion by 2030, growing at a CAGR of 5.6% from 2023 to 2030. Coffee whitener, available in liquid or granular form, serves as a milk substitute when added to coffee. Termed also as coffee creamer, its popularity is set to surge due to the growing vegan movement,
US Smart Cities Industry Development, Key Manufacturers and Forecast Report 2023-2030
US Smart Cities Industry Development, Key Manufacturers and Forecast Report 2023 …
Market Overview: The US Smart Cities Market is Expected to Grow at a Significant Growth Rate, and the Forecast Period is 2023-2030, Considering the Base Year as 2022. The US Smart Cities Market is a dynamic and rapidly evolving landscape focused on transforming urban areas through the integration of innovative technologies and data-driven solutions. Smart cities leverage digital infrastructure, IoT devices, data analytics, and connectivity to enhance the quality of life, sustainability,
Outdoor Tv Market Size, Share & Trends Analysis Report By Product , By Distribution Channel, By Region, And Segment Forecasts, 2023-30
Outdoor Tv Market Size, Share & Trends Analysis Report By Product , By Distribut …
Market Overview: The Outdoor Tv Market Is Expected To Grow At A Significant Growth Rate, And The Analysis Period Is 2023-2030, Considering The Base Year As 2023. Outdoor TVs are specifically designed and built to withstand various weather conditions and environmental factors, making them suitable for outdoor use in areas such as patios, decks, and other outdoor living spaces. They differ from indoor TVs in their durability, brightness, and weather-resistant features. One
Global Financial Wellness Benefits Market Size And Forecast 2023-2030 | With Top Key Palyers Aduro , Ayco ,Beacon Health Options
Global Financial Wellness Benefits Market Size And Forecast 2023-2030 | With Top …
Market Overview: The Financial Wellness Benefits Market is expected to grow at a significant growth rate, and the analysis period is 2023-2030, considering the base year as 2022. Financial wellness benefits refer to the programs and resources offered by companies to support the financial well-being of their employees. These benefits can include various tools, educational resources, and assistance programs that help employees save, invest, manage debt, budget effectively, and build financial resilience.

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top